Corrigendum: Antigen Presentation Machinery Signature-Derived CALR Mediates Migration, Polarization of Macrophages in Glioma and Predicts Immunotherapy Response

Front Immunol. 2022 Jun 2:13:931433. doi: 10.3389/fimmu.2022.931433. eCollection 2022.

Rui Chen¹, Hao Zhang^{2

3}, Wantao Wu^{3

4}, Shuyu Li⁵, Zeyu Wang^{2

3}, Ziyu Dai^{2

3}, Zaoqu Liu⁶, Jian Zhang⁷, Peng Luo⁷, Zhiwei Xia⁸, Quan Cheng^{2

3}

¹ Department of Neurosurgery, Affiliated Nanhua Hospital, University of South China, Hengyang, China.
² Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
³ National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.
⁴ Department of Oncology, Xiangya Hospital, Central South University, Changsha, China.
⁵ Department of Thyroid and Breast Surgery, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.
⁶ Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
⁷ Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
⁸ Department of Neurology, Hunan Aerospace Hospital, Changsha, China.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2022.833792.].

Keywords: antigen presentation machinery; genomic alteration; glioma; immunotherapy; microenvironment; prognosis.